Spiking-and-Recovery Experiment DOREMI Study

NCT02622347 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 30

Last updated 2017-05-16

No results posted yet for this study

Summary

The purpose of this study is to test the validity of our in-house chemiluminescence assay for measurement of folliclestimulating hormone (FSH) serum levels before and during exogenous recombinant FSH (rFSH) administration.

Conditions

  • FSH Assay

Sponsors & Collaborators

  • UMC Utrecht

    lead OTHER

Principal Investigators

  • Broekmans · UMC Utrecht

Eligibility

Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-08-31
Primary Completion
2017-04-30
Completion
2017-04-30

Countries

  • Netherlands

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02622347 on ClinicalTrials.gov